Legis Daily

Facilitating Innovative Nuclear Diagnostics Act of 2021

USA117th CongressHR-4479| House 
| Updated: 7/19/2021
Scott H. Peters

Scott H. Peters

Democratic Representative

California

Cosponsors (41)
Adrian Smith (Republican)Markwayne Mullin (Republican)Chris Pappas (Democratic)Tim Burchett (Republican)Guy Reschenthaler (Republican)Tom Malinowski (Democratic)Lisa Blunt Rochester (Democratic)Gregory F. Murphy (Republican)Darren Soto (Democratic)Jefferson Van Drew (Republican)Neal P. Dunn (Republican)Mariannette Miller-Meeks (Republican)Terri A. Sewell (Democratic)Bobby L. Rush (Democratic)Jackie Walorski (Republican)Tony Cárdenas (Democratic)Paul Tonko (Democratic)Angie Craig (Democratic)Donald M. Payne (Democratic)Earl L. "Buddy" Carter (Republican)Jake Auchincloss (Democratic)Ted Lieu (Democratic)David B. McKinley (Republican)Alan S. Lowenthal (Democratic)Ann M. Kuster (Democratic)A. Drew Ferguson (Republican)André Carson (Democratic)Christopher H. Smith (Republican)Dean Phillips (Democratic)John Joyce (Republican)Kelly Armstrong (Republican)Raja Krishnamoorthi (Democratic)John H. Rutherford (Republican)Bonnie Watson Coleman (Democratic)Larry Bucshon (Republican)Salud O. Carbajal (Democratic)James P. McGovern (Democratic)Lori Trahan (Democratic)Seth Moulton (Democratic)Bill Posey (Republican)Bill Johnson (Republican)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Facilitating Innovative Nuclear Diagnostics Act of 2021 This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2022 and as adjusted based on a specified fee schedule factor in each year thereafter.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jul 16, 2021
Introduced in House
Jul 16, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 16, 2021
Referred to the Subcommittee on Health.
Jul 19, 2021
Referred to the Subcommittee on Health.
Aug 4, 2021

Latest Companion Bill Action

S 117-2609
Introduced in Senate
  • July 16, 2021
    Introduced in House


  • July 16, 2021
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • July 16, 2021
    Referred to the Subcommittee on Health.


  • July 19, 2021
    Referred to the Subcommittee on Health.


  • August 4, 2021

    Latest Companion Bill Action

    S 117-2609
    Introduced in Senate

Health

Related Bills

  • S 117-2609: Facilitating Innovative Nuclear Diagnostics Act of 2021
Health care costs and insuranceMedical tests and diagnostic methodsMedicareRadiation

Facilitating Innovative Nuclear Diagnostics Act of 2021

USA117th CongressHR-4479| House 
| Updated: 7/19/2021
Facilitating Innovative Nuclear Diagnostics Act of 2021 This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2022 and as adjusted based on a specified fee schedule factor in each year thereafter.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jul 16, 2021
Introduced in House
Jul 16, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 16, 2021
Referred to the Subcommittee on Health.
Jul 19, 2021
Referred to the Subcommittee on Health.
Aug 4, 2021

Latest Companion Bill Action

S 117-2609
Introduced in Senate
  • July 16, 2021
    Introduced in House


  • July 16, 2021
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • July 16, 2021
    Referred to the Subcommittee on Health.


  • July 19, 2021
    Referred to the Subcommittee on Health.


  • August 4, 2021

    Latest Companion Bill Action

    S 117-2609
    Introduced in Senate
Scott H. Peters

Scott H. Peters

Democratic Representative

California

Cosponsors (41)
Adrian Smith (Republican)Markwayne Mullin (Republican)Chris Pappas (Democratic)Tim Burchett (Republican)Guy Reschenthaler (Republican)Tom Malinowski (Democratic)Lisa Blunt Rochester (Democratic)Gregory F. Murphy (Republican)Darren Soto (Democratic)Jefferson Van Drew (Republican)Neal P. Dunn (Republican)Mariannette Miller-Meeks (Republican)Terri A. Sewell (Democratic)Bobby L. Rush (Democratic)Jackie Walorski (Republican)Tony Cárdenas (Democratic)Paul Tonko (Democratic)Angie Craig (Democratic)Donald M. Payne (Democratic)Earl L. "Buddy" Carter (Republican)Jake Auchincloss (Democratic)Ted Lieu (Democratic)David B. McKinley (Republican)Alan S. Lowenthal (Democratic)Ann M. Kuster (Democratic)A. Drew Ferguson (Republican)André Carson (Democratic)Christopher H. Smith (Republican)Dean Phillips (Democratic)John Joyce (Republican)Kelly Armstrong (Republican)Raja Krishnamoorthi (Democratic)John H. Rutherford (Republican)Bonnie Watson Coleman (Democratic)Larry Bucshon (Republican)Salud O. Carbajal (Democratic)James P. McGovern (Democratic)Lori Trahan (Democratic)Seth Moulton (Democratic)Bill Posey (Republican)Bill Johnson (Republican)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • S 117-2609: Facilitating Innovative Nuclear Diagnostics Act of 2021
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Health care costs and insuranceMedical tests and diagnostic methodsMedicareRadiation